Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Switzerland
/
Pharmaceuticals & Biotech
Create a narrative
Roche Holding Community
SWX:ROG Community
2
Narratives
written by author
0
Comments
on narratives written by author
202
Fair Values set
on narratives written by author
Create a narrative
Roche Holding
Popular
Undervalued
Overvalued
Community Investing Ideas
Roche Holding
BA
bazza
Community Contributor
Roche Holding will see a 4.2576% revenue growth shaking the market
Valuation ### **Analyse der Roche Jahreszahlen 2024: Wachstum setzt sich fort, Herausforderungen bleiben_20250130 #### Zusammenfassung der Ergebnisse Roche hat für das Jahr 2024 ein solides Wachstum von 7 % auf 60,5 Mrd. CHF erzielt, was die Erwartungen leicht übertroffen hat.
View narrative
CHF 302.06
FV
13.9% undervalued
intrinsic discount
5.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
4 months ago
author updated this narrative
Roche Holding
AN
AnalystConsensusTarget
Consensus Narrative from 20 Analysts
Advancing 7 New Therapies And Poseida Acquisition Will Expand Presence In Oncology By 2025
Key Takeaways Successful Pharma pipeline and innovative diagnostics launches are anticipated to drive long-term revenue growth and operating profit. Investments in strategic R&D and acquisition capabilities aim to enhance core profit and sustain competitive position in medicine development.
View narrative
CHF 305.08
FV
14.7% undervalued
intrinsic discount
2.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
128
users have followed this narrative
about 22 hours ago
author updated this narrative
Your Valuation for
ROG
ROG
Roche Holding
Your Fair Value
CHF
Current Price
CHF 260.20
0.8% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
74b
2015
2018
2021
2024
2025
2027
2030
Revenue CHF 74.3b
Earnings CHF 9.9b
Advanced
Set Fair Value